Webinar Replay: AML Genetic Testing and Me

Published on

Topics include: Treatment , Understanding and Treatment | General

Genetic testing can help physicians to better understand an individual’s AML and help guide treatment decisions. So which genetic tests should AML patients have and when? In this Patient Empowerment Network program, in partnership with The Leukemia & Lymphoma Society (LLS), an expert panel discusses essential genetic testing for AML patients. Dr. Lee Greenberger, Chief Scientific Officer at the LLS is joined by AML specialist Dr. Amit Verma and patient advocate Kuldip Ahluwalia as they explain this complex topic and share tools for patients to help ensure they get the best care.

This was a Patient Empowerment Network program produced by Patient Power, in partnership with The Leukemia & Lymphoma Society (LLS). We thank Astellas, Celgene Corporation, Novartis, Pfizer and Seattle Genetics for their support.

View more programs featuring , , and

Produced in association with

Related Programs

Targeted Therapy: Finding the Right Treatment Option for Your AML

With several newly approved AML treatments, how do you know which is right for you? Dr. Michael Deininger discusses current AML medicines and ones on the horizon.

Published:

What are my options if the first treatment does not work?

What are my options if the first treatment does not work?

Published:

I've Been Diagnosed With Acute Myeloid Leukaemia (AML): What Happens Now?

At the stage of diagnosis, acute myeloid leukaemia (AML) patients often have to be hospitalised, due to the severe symptoms presented. Dr. Charles Craddock of the Queen Elizabeth Hospital in Birmingham, UK, describes next steps.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on November 3, 2017